ACCELYS
Live / Allowed — Publication / registration review complete (as of 16 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99300745
- Mark type
- Stylized text
- Filed
- 24 Jul 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Boris Umansky
Goods and services
- Class 042 — Scientific and technological services: Providing information, advice and consultancy relating to testing, inspection and research services in the fields of pharmaceuticals; chemistry consultation; consultancy relating to pharmaceutical research and development; consultancy in the field of pharmacology; research in the field of pharmaceuticals; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; research on the subject of pharmaceuticals; drug discovery services; pharmaceutical research services; development of pharmaceutical preparations and medicines; medical research; chemical research; research in the field of chemistry; chemical analysis; bacteriological research; biological research; scientific research in the nature of conducting clinical trials for others; scientific research; scientific laboratory services.
Owner
- Accelys Pharma, Inc., Minato-ku, Tokyo, JP
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Dec 2025 — NON-FINAL ACTION E-MAILED
- 10 Dec 2025 — NON-FINAL ACTION WRITTEN
- 10 Dec 2025 — ASSIGNED TO EXAMINER
- 02 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 24 Jul 2025 — NEW APPLICATION ENTERED